Robert Jankov obtained his MBBS at the University of Melbourne, Australia and completed his residency training in paediatrics at the Royal Children’s Hospital, also in Melbourne. He subsequently completed a Clinical Fellowship in Neonatal-Perinatal Medicine at the University of Toronto from1996 to 1999, which was followed by a PhD from 2001 to 2004 in the Department of Physiology, University of Toronto. He was previously a Staff Neonatologist and Senior Scientist at Sunnybrook Health Sciences Centre and the Hospital for Sick Children, Toronto.
Overview of research:
Dr. Jankov’s research has continuously focused upon an improved understanding of chronic pulmonary vascular disease, which in the neonate predominantly occurs in the context of bronchopulmonary dysplasia (BPD) and other developmental lung disorders. His research interests include the cellular and molecular mechanisms of vascular remodelling, right-ventricular dysfunction and nitric oxide unresponsiveness in pulmonary hypertension during early life. The overall objective of his research program is to delineate critical factors underlying pathogenesis that will inform new therapies. Current areas of focus using novel animal models developed in his laboratory include therapies targeting Rho-kinase activity, thrombospondin signaling and arginine-nitric oxide dysfunction. The CIHR and the Heart and Stroke Foundation of Canada fund his work.